• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭的代谢起源

Metabolic Origins of Heart Failure.

作者信息

Wende Adam R, Brahma Manoja K, McGinnis Graham R, Young Martin E

机构信息

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

JACC Basic Transl Sci. 2017 Jun;2(3):297-310. doi: 10.1016/j.jacbts.2016.11.009.

DOI:10.1016/j.jacbts.2016.11.009
PMID:28944310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5609457/
Abstract

For more than half a century, metabolic perturbations have been explored in the failing myocardium, highlighting a reversion to a more fetal-like metabolic profile (characterized by depressed fatty acid oxidation and concomitant increased reliance on glucose utilization). More recently, alterations in ketone body and amino acid/protein metabolism have been described during heart failure, as well as mitochondrial dysfunction and perturbed metabolic signaling (e.g., acetylation, O-GlcNAcylation). Although numerous mechanisms are likely involved, the current review provides recent advances regarding the metabolic origins of heart failure, and their potential contribution toward contractile dysfunction of the heart.

摘要

半个多世纪以来,人们一直在研究衰竭心肌中的代谢紊乱,突出显示其向更类似胎儿的代谢模式转变(其特征为脂肪酸氧化降低以及对葡萄糖利用的依赖性增加)。最近,心力衰竭期间酮体和氨基酸/蛋白质代谢的改变、线粒体功能障碍以及代谢信号传导紊乱(如乙酰化、O-连接的N-乙酰葡糖胺化)也得到了描述。尽管可能涉及多种机制,但本综述介绍了心力衰竭代谢起源方面的最新进展,以及它们对心脏收缩功能障碍的潜在影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/51a354e8c830/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/5b5a8f7748a5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/b30b7305dde1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/8e88d2aa4baf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/7e4f58c3bb56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/5b5a8f7748a5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/51a354e8c830/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/5b5a8f7748a5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/b30b7305dde1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/8e88d2aa4baf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/7e4f58c3bb56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/5b5a8f7748a5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e96c/6034439/51a354e8c830/gr4.jpg

相似文献

1
Metabolic Origins of Heart Failure.心力衰竭的代谢起源
JACC Basic Transl Sci. 2017 Jun;2(3):297-310. doi: 10.1016/j.jacbts.2016.11.009.
2
Loss of Metabolic Flexibility in the Failing Heart.衰竭心脏中代谢灵活性的丧失。
Front Cardiovasc Med. 2018 Jun 6;5:68. doi: 10.3389/fcvm.2018.00068. eCollection 2018.
3
Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.酮体氧化增加为衰竭的心脏提供了额外的能量,而不改善心脏效率。
Cardiovasc Res. 2019 Sep 1;115(11):1606-1616. doi: 10.1093/cvr/cvz045.
4
Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.靶向脂肪酸和碳水化合物氧化——缺血性和衰竭心脏的一种新型治疗干预措施。
Biochim Biophys Acta. 2011 Jul;1813(7):1333-50. doi: 10.1016/j.bbamcr.2011.01.015. Epub 2011 Jan 20.
5
Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.心力衰竭中的心肌能量底物代谢:从途径到治疗靶点
Curr Pharm Des. 2015;21(25):3654-64. doi: 10.2174/1381612821666150710150445.
6
Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.肥胖、糖尿病和心力衰竭中心脏脂肪酸β氧化及能量代谢的乙酰化调控
Biochim Biophys Acta. 2016 Dec;1862(12):2211-2220. doi: 10.1016/j.bbadis.2016.07.020. Epub 2016 Jul 29.
7
Altered systemic ketone body metabolism in advanced heart failure.晚期心力衰竭时全身酮体代谢的改变。
Tex Heart Inst J. 2011;38(5):533-8.
8
Ketone metabolism in the failing heart.衰竭心脏中的酮体代谢。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec;1865(12):158813. doi: 10.1016/j.bbalip.2020.158813. Epub 2020 Sep 10.
9
Metabolic therapy of heart failure.心力衰竭的代谢治疗
Curr Pharm Des. 2008;14(25):2582-91. doi: 10.2174/138161208786071245.
10
Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.心力衰竭、缺血性心脏病和糖尿病性心肌病中的线粒体脂肪酸氧化改变
Br J Pharmacol. 2014 Apr;171(8):2080-90. doi: 10.1111/bph.12475.

引用本文的文献

1
Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms-a comprehensive review.心血管-肾脏-代谢综合征中的炎症:关键作用及潜在机制——综述
Mol Cell Biochem. 2025 Sep 10. doi: 10.1007/s11010-025-05379-9.
2
Effects of angiotensin receptor-neprilysin inhibition on myocardial energy metabolism and prognosis in patients with acute myocardial infarction complicated by heart failure.血管紧张素受体-中性肽链内切酶抑制对急性心肌梗死合并心力衰竭患者心肌能量代谢及预后的影响
Front Cardiovasc Med. 2025 Aug 12;12:1550624. doi: 10.3389/fcvm.2025.1550624. eCollection 2025.
3
A gene regulatory element modulates myosin expression and controls cardiomyocyte response to stress.

本文引用的文献

1
Impact of empagliflozin in patients with diabetes and heart failure.恩格列净对糖尿病合并心力衰竭患者的影响。
Trends Cardiovasc Med. 2017 Feb;27(2):144-151. doi: 10.1016/j.tcm.2016.07.008. Epub 2016 Aug 4.
2
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.钠-葡萄糖协同转运蛋白2抑制剂在糖尿病治疗中的应用:心血管和肾脏效应、潜在机制及临床应用
Circulation. 2016 Sep 6;134(10):752-72. doi: 10.1161/CIRCULATIONAHA.116.021887. Epub 2016 Jul 28.
3
Molecular profiling of dilated cardiomyopathy that progresses to heart failure.
一种基因调控元件可调节肌球蛋白表达并控制心肌细胞对应激的反应。
bioRxiv. 2025 Jul 20:2025.07.19.665672. doi: 10.1101/2025.07.19.665672.
4
Metabolism-related gene PDK1 regulates myocardial cell remodeling and its mechanism.代谢相关基因PDK1调控心肌细胞重塑及其机制。
Stem Cell Res Ther. 2025 Jul 26;16(1):404. doi: 10.1186/s13287-025-04518-9.
5
Modulation of cardiac fatty acid or glucose oxidation to treat heart failure in preclinical models: a systematic review and meta-analysis.在临床前模型中调节心脏脂肪酸或葡萄糖氧化以治疗心力衰竭:一项系统评价和荟萃分析。
Commun Med (Lond). 2025 Jun 4;5(1):213. doi: 10.1038/s43856-025-00924-5.
6
The cardioprotective effect of whey protein against thioacetamide-induced toxicity through its antioxidant, anti-inflammatory, and anti-apoptotic effects in male albino rats.乳清蛋白通过其抗氧化、抗炎和抗凋亡作用对硫代乙酰胺诱导的雄性白化大鼠毒性的心脏保护作用。
Front Vet Sci. 2025 May 19;12:1590722. doi: 10.3389/fvets.2025.1590722. eCollection 2025.
7
Chronic stress elicits sex-specific mitochondrial respiratory functional changes in the rat heart.慢性应激引发大鼠心脏中性别特异性的线粒体呼吸功能变化。
Physiol Rep. 2025 May;13(9):e70371. doi: 10.14814/phy2.70371.
8
Application of Metabolomics and the Discovery of Potential Serum Biomarkers for Diuretic Resistance in Heart Failure.代谢组学在心力衰竭利尿剂抵抗潜在血清生物标志物发现中的应用
Rev Cardiovasc Med. 2025 Apr 22;26(4):27001. doi: 10.31083/RCM27001. eCollection 2025 Apr.
9
The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure.钠-葡萄糖协同转运蛋白2抑制剂在心力衰竭各阶段的作用及早期临床获益机制:从预防到晚期心力衰竭
Biomedicines. 2025 Mar 3;13(3):608. doi: 10.3390/biomedicines13030608.
10
Myocardial Viability: Evolving Insights and Challenges in Revascularization and Functional Recovery.心肌存活:血运重建与功能恢复方面不断发展的见解与挑战
J Cardiovasc Dev Dis. 2025 Mar 20;12(3):106. doi: 10.3390/jcdd12030106.
进展为心力衰竭的扩张型心肌病的分子特征分析。
JCI Insight. 2016 May 5;1(6). doi: 10.1172/jci.insight.86898.
4
Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.支链氨基酸的分解代谢缺陷促进心力衰竭。
Circulation. 2016 May 24;133(21):2038-49. doi: 10.1161/CIRCULATIONAHA.115.020226. Epub 2016 Apr 8.
5
Insulin Signaling and Heart Failure.胰岛素信号传导与心力衰竭
Circ Res. 2016 Apr 1;118(7):1151-69. doi: 10.1161/CIRCRESAHA.116.306206.
6
Exhaled Acetone Concentration Is Related to Hemodynamic Severity in Patients With Non-Ischemic Chronic Heart Failure.呼出丙酮浓度与非缺血性慢性心力衰竭患者的血流动力学严重程度相关。
Circ J. 2016 Apr 25;80(5):1178-86. doi: 10.1253/circj.CJ-16-0011. Epub 2016 Mar 29.
7
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.阿霉素通过抑制溶酶体酸化来阻断心肌细胞自噬流。
Circulation. 2016 Apr 26;133(17):1668-87. doi: 10.1161/CIRCULATIONAHA.115.017443. Epub 2016 Mar 16.
8
Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure.依赖动力相关蛋白1(Drp1)的线粒体自噬对压力超负荷诱导的线粒体功能障碍和心力衰竭起保护作用。
Circulation. 2016 Mar 29;133(13):1249-63. doi: 10.1161/CIRCULATIONAHA.115.020502. Epub 2016 Feb 25.
9
The Failing Heart Relies on Ketone Bodies as a Fuel.衰竭心脏依赖酮体作为燃料。
Circulation. 2016 Feb 23;133(8):698-705. doi: 10.1161/CIRCULATIONAHA.115.017355. Epub 2016 Jan 27.
10
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.晚期人类心力衰竭中心肌内脂质代谢紊乱及心肌酮利用增加的证据。
Circulation. 2016 Feb 23;133(8):706-16. doi: 10.1161/CIRCULATIONAHA.115.017545. Epub 2016 Jan 27.